4-Hydroxy-6,7-dihydro-5H-pyrrolo<3,4-d>pyrimidin

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 4-Hydroxy-6,7-dihydro-5H-pyrrolo<3,4-d>pyrimidin
• 英文别名: 3,5,6,7-tetrahydro-pyrrolo[3,4-d]pyrimidin-4-one；1,5,6,7-Tetrahydropyrrolo[3,4-d]pyrimidin-4-one；3,5,6,7-tetrahydropyrrolo[3,4-d]pyrimidin-4-one
• 化学式: C₆H₇N₃O
• 分子量: 137.141
• InChiKey: LGCQRMCNOJGREM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.8
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  53.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• 2-SUBSTITUTED PHENYL-5,7-DIALKYL-3,7-DIHYDROPYRROLE[2,3-D]PYRIMIDINE-4-ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
  申请人：Tianjin Tasly Group Co., Ltd.

  公开号：EP1634883A1

  公开（公告）日：2006-03-15

  The invention relates to the compounds of formula I, their preparation and the pharmaceutical compositions containing the compounds. The invention also relates to the use of the compounds of formula I in preparing medicines, which can treat sexual dysfunction of animals including human (male and female), especially erectile dysfunction of male and the diseases in which the function of phospholipase 5 (cGMP PDE5) is involved.

  本发明涉及式 I 化合物、其制备方法以及含有该化合物的药物组合物。本发明还涉及式 I 化合物在制备药物中的用途，这些药物可治疗包括人类（雄性和雌性）在内的动物的性功能障碍，尤其是雄性动物的勃起功能障碍以及磷脂酶 5（cGMP PDE5）功能参与的疾病。
• 2-Substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole &lsqb;2,3-d&rsqb;pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
  申请人：Wang Yongfeng

  公开号：US20060173025A1

  公开（公告）日：2006-08-03

  The invention relates to the compounds of formula I, their preparation and the pharmaceutical compositions containing the compounds. The invention also relates to the use of the compounds of formula I in preparing medicines, which can treat sexual dysfunction of animals including human (male and female), especially erectile dysfunction of male and the diseases in which the function of phospholipase 5 (cGMP PDE5) is involved.

  本发明涉及式 I 化合物、其制备方法以及含有该化合物的药物组合物。本发明还涉及式 I 化合物在制备药物中的用途，这些药物可治疗包括人类（雄性和雌性）在内的动物的性功能障碍，尤其是雄性动物的勃起功能障碍以及磷脂酶 5（cGMP PDE5）功能参与的疾病。
• 2-SUBSTITUTED PHENYL-5,7-DIALKYL-3,7-DIHYDROPYRROLE[2,3-D] PYRIMIDINE-4-ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
  申请人：Yangtze River Pharmaceutical Group Co., Ltd.

  公开号：EP1634883B1

  公开（公告）日：2010-12-15
• 2-substituted phenyl-5, 7-dehydrocarbyl-3, 7-dihydropyrrolo [2, 3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
  申请人：Wang Yongfeng

  公开号：US20080167462A1

  公开（公告）日：2008-07-10

  The invention relates to the compounds of formula I, their preparation and the pharmaceutical compositions containing the compounds. The invention also relates to the use of the compounds of formula I in preparing medicines, which can treat sexual dysfunction of animals including human (male and female), especially erectile dysfunction of male and the diseases in which the function of phospholipase 5 (cGMP PDE5) is involved.
• 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
  申请人：Wang Yongfeng

  公开号：US20100204223A1

  公开（公告）日：2010-08-12

  The invention relates to the compounds of formula I, their preparation and the pharmaceutical compositions containing the compounds. The invention also relates to the use of the compounds of formula I in preparing medicines, which can treat sexual dysfunction of animals including human (male and female), especially erectile dysfunction of male and the diseases in which the function of phospholipase 5 (cGMP PDE5) is involved.